HCM
HUTCHMED (China) Ltd
$11.25
+0.11 (+0.99%)
At close · Jul 14
Market Cap
$1.99B
Shares
171,950,364
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.25
Open$11.14
Day$11.14–11.33
52W$9.77–19.50
Avg vol 30d60K
Short int198K · 0.1% float · 4.1d
Short vol40%
Last earningsJun 30, 2023
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
High
Market backdrop
VIX 16.5 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
−2%
below
RSI (14)
53
neutral
MACD trend
Positive
52-week position
15%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−28%
trailing
YTD return
−16%
this year
Relative strength
−39%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.12% of float · ▼ -1.2% MoM · 4.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
54 holders — mid 3-yr range
Squeeze score
45
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
EPS growth
+1200%
Y/Y
Free cash flow
$-78.8M
Balance sheet
$21.8M
net debt
Quant / Vol
risk profile
Volatility
37%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
3.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
15%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $11 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.12% of float · ▼ -1.2% MoM · 4.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
54 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $10
Now $11 · 15%
52-wk high $20
vs 200-day avg -19%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HCM
this stock
HUTCHMED (China) Ltd
|
$1.99B | -15.6% | +11.3% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.45B | +5.1% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$48.68B | +0.2% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.98B | -4.1% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HCM | +1.5% | +2.7% | -28.0% | +4.6% | -15.6% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | +1.0% | +1.3% | -38.9% | +3.9% | -25.9% |
Key facts
CIK
1648257
CUSIP
44842L103
13F (30d)
20 filings
1 filers
Visit website
Investor relations